Browse products
Pharmaceutical market in Romania 2008Development forecasts for 2008-2010 |
Our clients say...
Pharmaceutical market in Romania 2008 paints a comprehensive portrait of the Romanian pharmaceutical market and its path of growth and development during the period from 2002-2008. Data, analysis, solid, detailed forecasts for the period 2008-2010, along with pharmacy and hospital outlet activities and complete market value data presented by segment combine to help readers achieve a working knowledge of all facets of this complicated market.
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ”
General Manager, Sanofi-Synthelabo
“PMR provides a good service and is always open to discussion. All reports are well structured & are always on time.”
Member of the Managment Board, SCA Hygiene Products
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.”
Business Analyst, Hilti Distribution, Russia
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.”
General Manager, Sanofi-Synthelabo
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.”
Development Manager, GVA Grimley
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales.
”
Market Analyst, Alpha Cement
Fresh and reliable data is carefully followed up with expert analysis of the market’s most influential factors, including: epidemiologist, demographics, and prevailing conditions in the Romanian health care and legal systems.
Pharmaceutical market in Romania 2008 also provides a comprehensive source of useful information concerning the market’s major players, their market shares and financials, along with detailed profiles of the ten top performers. Information gleaned through in-depth interviews with market experts enhances the value of this timely document, as does its astute analysis of data and market trends with regard to wholesale and retail trends in distribution and sales and the distributors and pharmacy chains engaged in these pharmaceutical market activities.
Report overview
Pharmaceutical market in Romania 2008 provides a comprehensive overview of the recent and current market segments, and analyses the effects of prevailing trends on the market as a whole as well as on the following segments, while forecasting trends for:
- Rx, retail and hospital market
- domestically produced and imported drugs 2002-2010
- original and generic drugs 2002-2010.
Given the complicated nature of the wide variety of products available on the pharmaceutical market, this report breaks them down by therapeutic category, exploring the largest groups and defining their respective market shares. The groups include:
- cardiovascular system drugs
- central nervous system drugs drugs
- used to treat the alimentary tract and metabolic issues
- respiratory system drugs
- anti-infectives
- musculo-skeletal system drugs
- genito-urinary system drugs
- antineoplastics and immunomodulating agents
- blood and blood forming organs
- other ATC groups.
A study of the companies that manufacture, distribute and export pharmaceuticals in is vital to a comprehensive understanding of the market and its activities. In addition to a general overview of top companies 2002-2006, the report offers details on:
- largest exporters, providing profiles of export activity
- rankings of top 20 companies – 2007 and H1 2008
- profiles of the largest ten companies.
Every market responds to trends, events and governmental activities that influence consumer habits and the conduct of business in general. Pharmaceutical market in Romania 2008 describes those demographic and epidemiological trends and health care and legal system conditions that affect the market, providing the latest information on:
- population, aging and life expectancy trends
- mortality and morbidity factors
- prevalent trends affecting the health care system
- drug expenditures
- legislation and applicable institutions, EU
- legislation, and market authorization
- patent protection, advertising and product
- pricing procedures.
Drug distribution in is affected by events and trends, and these are outlined in the report, along with anticipated conditions likely to prevail in 2008-2009. Profiles include:
- pharmaceutical wholesalers – segment profile and financial results and characteristics of key players
- pharmacy distribution – segment profile and financial results and characteristics of key players.
As a valuable enhancement, Pharmaceutical market in Romania 2008 features a directory of the 50 largest pharmaceutical companies active on the Romanian market. The report functions as a useful tool for:
- companies currently active on the Romanian pharmaceutical market
- companies considering market entry into Romanian pharmaceuticals
- consulting and research companies and analytical institutes
- government agencies, embassies and other trade organizations
Request sample pages/interactive screenshare
Report methodology
Executive summary
Overview of the pharmaceutical market in Romania
- Major trends and events on the Romanian pharmaceutical market
- Major trends 2007-2008
- Key events 2007-2008
- Anticipated key trends and events 2008-2010
- Size of the Romanian pharmaceutical market 2002-2010
- Total market value in the years 2002-2010
- Retail and hospital markets in the years 2002-2010
- Rx market in the years 2002-2010
- Domestically produced and imported drugs in the years 2002-2010
- Original and generic drugs in the years 2002-2010
- Average prices of drugs in Romania
Pharmaceutical market by therapeutic groups
- Cardiovascular system
- Metabolism and alimentary tract
- Anti-infectives
- Central nervous system
- Antineoplastic and immunostimulating agents
- Respiratory system
- Musculo-skeletal system
- Blood and blood forming organs
- Genito-urinary system
- Dermatologicals
Economic analysis of the Romanian pharmaceutical industry
- General overview
- Foreign trade
- Actavis exports
- Terapia Ranbaxy exports
- Antibiotice exports
- Zentiva (Sicomed) exports
- Biofarm and LaborMed exports
- Ranking of the largest drug manufacturers
- Profiles of major market players
- Major investments on the Romanian pharmaceutical market
Distribution
- Key events and trends on the distribution market 2002-2008
- Anticipated trends on the distribution market 2008-2009
- Pharmaceutical wholesalers
- Subdivision profile
- Key players
- Pharmacy distribution
- Subgroup profile
- Geographical dispersal
- General rules for running a pharmacy
- Number and categories of pharmacies
- Key players
- Non-pharmacy sales
- Online sales
Factors which influence the Romanian pharmaceutical market
- Demographic trends
- Population
- Ageing of society
- Life expectancy
- Epidemiological trends
- Mortality
- Morbidity
- Healthcare system
- Spending on drugs
- Legal environment
- Main legislation and institutions governing pharmaceuticals in Romania
- Market authorisation
- General rules
- Mutual Recognition Procedure
- Fees for Market Authorisation
- Patent protection
- Advertising of medicines
- Pricing procedures
- VAT and duties
- Retail and wholesale margins
- Reimbursement system
List of graphs
List of tables
About PMR
Contact PMR
List of graphs
- Value (€ m) and y-o-y growth of the pharmaceutical market in Romania, 2002-2010
- Value (€ m) and y-o-y change of the pharmaceutical market in Romania, 2002-2010
- Value (€ m) and y-o-y change of the retail pharmaceutical market in Romania, 2002-2010
- Value (€ m) and y-o-y change of the hospital pharmaceutical market in Romania, 2002-2010
- Share of retail and hospital market as a proportion of total pharmaceutical market value in Romania, 2002-2010
- Value (€ m) and y-o-y change of the retail Rx market in Romania, 2002-2010
- Comparison of y-o-y growth of Rx and OTC sales in Romania, 2003-2007
- Value (€ m) and y-o-y change in imported drugs in Romania, 2002-2010
- Value (€ m) and y-o-y change of domestic drugs in Romania, 2002-2010
- Share of domestic and foreign drugs as a proportion of total pharmaceutical market value in Romania, 2002-2010
- Share of innovative and generic drugs as a proportion of total pharmaceutical market value in Romania, 2003-2010
- Value (€ m) and y-o-y change of generic drugs in Romania, 2002-2010
- Value (€ m) and y-o-y change of non-generic drugs in Romania, 2002-2010
- Average prices of drugs in Romania (€ per one package), by therapeutic category, 2007
- Average prices of drugs in selected EU countries (€ per one tablet), 2008
- Pharmaceutical market by ATC categories in terms of value in Romania, 2007
- Pharmaceutical market by ATC categories in terms of value in Romania, Q1 2007-Q1 2008
- Sales (RON m) and y-o-y increase in cardiovascular drugs in Romania, 2005-2010
- Top 10 companies in cardiovascular drug subgroup, by value, Q1 2008
- Sales (RON m) and y-o-y change in drugs used in alimentary tract and metabolic diseases in Romania, 2005-2010
- Sales (RON m) and y-o-y increase of anti-infectives in Romania, 2005-2010
- Sales (RON m) and y-o-y increase in drugs used for CNS diseases in Romania, 2005-2010
- Sales (RON m) and y-o-y increase in antineoplastic and immunostimulating agents in Romania, 2005-2010
- Sales (RON m) and y-o-y change in drugs used for respiratory system diseases in Romania, 2005-2010
- Sales (RON m) and y-o-y change in drugs used for musculo-sceletal system diseases in Romania, 2005-2010
- Sales (RON m) and y-o-y change in drugs used for blood and blood forming organs diseases in Romania, 2005-2010
- Sales (RON m) and y-o-y change in drugs used to treat genito-urinary system diseases in Romania, 2005-2010
- Sales (RON m) and y-o-y change in dermatologicals in Romania, 2005-2010
- Actavis Romania export sales (€ m), 2006-2008
- Terapia Ranbaxy export sales (€ m), 2006-2007
- Antibiotice export sales (€ m), 2006-2008
- Shares of top 10 manufacturers on the pharmaceutical market in Romania, by value, 2007
- Shares of top 10 manufacturers on the pharmaceutical market in Romania, by value, H1 2008
- GSK sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
- Novartis sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
- Roche sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
- Sanofi-Aventis sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
- Servier sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
- Pfizer sales revenue (RON m) and y-o-y change in Romania, 2005-2007
- Terapia Ranbaxy sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
- Zentiva sales revenue (RON m) and y-o-y change in Romania, 2005-2007
- Antibiotice sales revenue (RON m) and y-o-y change in Romania, 2005-2007
- Krka sales revenue (RON m) and y-o-y growth in Romania, 2005-2007
- Market shares of the largest pharmaceutical distributors in Romania, retail market, 2007
- Market shares of the largest pharmaceutical distributors in Romania, hospital market, 2007
- Market share of the largest pharmaceutical distributors in Romania, total market, 2007
- Mediplus revenues (€ m) in Romania, 2002-2008
- Relad Group turnover (€ m) in Romania, 2006-2007
- Fildas Group turnover (€ m) in Romania, 2006-2007
- Polisano’s turnover (€ m) in Romania, 2006-2007
- Farmexpert annual turnover (€ m) in Romania, 2006-2008
- Farmexim turnover (€ m) in Romania, 2006-2008
- Largest pharmacy chains in Romania (number of pharmacies), 2008
- Population of Romania (’000), 1989-2007
- Proportion of age groups in population in Romania, 2007
- Percentage of deaths caused by cardiovascular diseases in Romania, 1989-2006
- Percentage of deaths caused by tumours in Romania, 1989-2006
- Percentage of deaths caused by respiratory diseases in Romania, 1989-2006
- Percentage of deaths caused by injury, poisoning and other external causes in Romania, 1989-2006
- Percentage of deaths caused by digestive system diseases in Romania, 1989-2006
- Morbidity in Romania (% of total diseases), 2006
- Expenditure on health (€ m) and y-o-y change in Romania, 2000-2006
- Per capita expenditure on health (€) and y-o-y change in Romania, 2000-2006
- Per capita drug spending ($) in selected CEE countries, 2006
List of tables
- Best selling generics in Romania, October 2006-September 2007
- Average prices of drugs in Romania (€ per one package), by distribution channel and availability category, 2007
- Best selling cardiovascular drugs in Romania and their market shares, Q1 2008
- Sales value of the 20 largest manufacturers on the pharmaceutical market in Romania (RON, €), 2007
- Sales value of the 20 largest manufacturers on the pharmaceutical market in Romania (RON, €), Q1 2008 and 2008
- Other causes of deaths in Romania (number of deaths per 100,000 inhabitants), 1989-2006
- MRP in Romania, 2008
- Tariffs for the administration of the Evaluation-Authorisation Department in Romania, 2008
- Retail margins on drugs in Romania, 2008
Pharmaceutical market in Romania 2008
Development forecasts for 2008-2010
Choose your version of this product:
| Language / Licence | Single | 5 Users | Corporate | Global |
| English | 1600€ | 2400€ | 3200€ | 4000€ |
Compare licences
- - for the product preservation: saving the product in the memory of one computer belonging to the client;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.